Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Associations of Selenoprotein Genetic Variants with the Risks of Colorectal Adenoma and Colorectal Cancer: Case-Control Studies in Irish and Czech Populations

M. Mukhtar, N. Ashfield, L. Vodickova, V. Vymetalkova, M. Levy, V. Liska, J. Bruha, P. Bendova, J. O'Sullivan, G. Doherty, K. Sheahan, B. Nolan, P. Vodicka, DJ. Hughes

. 2022 ; 14 (13) : . [pub] 20220629

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22025389

Grantová podpora
HRA-POS/2013/397 Health Research Board of Ireland
31312020 International Hundred K+ Cohorts Consortium/Global Genomic Medicine Collaborative (IHCC/G2MC)
GACR 20-03997S Czech Science Foundation
VV 22-05942S Czech Science Foundation
AZV NV18-03-00199 Czech Health Research council of the Ministry of Health of the Czech Republic

BACKGROUND: Selenium manifests its biological effects through its incorporation into selenoproteins, which play several roles in countering oxidative and inflammatory responses implicated in colorectal carcinogenesis. Selenoprotein genetic variants may contribute to colorectal cancer (CRC) development, as we previously observed for SNP variants in a large European prospective study and a Czech case-control cohort. METHODS: We tested if significantly associated selenoprotein gene SNPs from these studies were also associated with CRC risk in case-control studies from Ireland (colorectal neoplasia, i.e., cancer and adenoma cases: 450, controls: 461) and the Czech Republic (CRC cases: 718, controls: 646). Genotyping of 23 SNPs (20 in the Irish and 13 in the Czechs) was performed by competitive specific allele-specific PCR (KASPar). Multivariable adjusted logistic regression was used to assess the associations with CRC development. RESULTS: We found significant associations with an increased CRC risk for rs5859 (SELENOF) and rs2972994 (SELENOP) in the Irish cohort but only with rs4802034 (SELENOV) in the Czechs. Significant associations were observed for rs5859 (SELENOF), rs4659382 (SELENON), rs2972994 (SELENOP), rs34713741 (SELENOS), and the related Se metabolism gene variant rs2275129 (SEPHS1) with advanced colorectal neoplasia development. However, none of these findings retained significance after multiple testing corrections. CONCLUSIONS: Several SNPs previously associated with CRC risk were also associated with CRC or colorectal neoplasia development in either the Irish or Czech cohorts. Selenoprotein gene variation may modify CRC risk across diverse European populations, although the specific variants may differ.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025389
003      
CZ-PrNML
005      
20221031100510.0
007      
ta
008      
221017s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu14132718 $2 doi
035    __
$a (PubMed)35807897
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Mukhtar, Maryam $u Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland $1 https://orcid.org/0000000335715447
245    14
$a The Associations of Selenoprotein Genetic Variants with the Risks of Colorectal Adenoma and Colorectal Cancer: Case-Control Studies in Irish and Czech Populations / $c M. Mukhtar, N. Ashfield, L. Vodickova, V. Vymetalkova, M. Levy, V. Liska, J. Bruha, P. Bendova, J. O'Sullivan, G. Doherty, K. Sheahan, B. Nolan, P. Vodicka, DJ. Hughes
520    9_
$a BACKGROUND: Selenium manifests its biological effects through its incorporation into selenoproteins, which play several roles in countering oxidative and inflammatory responses implicated in colorectal carcinogenesis. Selenoprotein genetic variants may contribute to colorectal cancer (CRC) development, as we previously observed for SNP variants in a large European prospective study and a Czech case-control cohort. METHODS: We tested if significantly associated selenoprotein gene SNPs from these studies were also associated with CRC risk in case-control studies from Ireland (colorectal neoplasia, i.e., cancer and adenoma cases: 450, controls: 461) and the Czech Republic (CRC cases: 718, controls: 646). Genotyping of 23 SNPs (20 in the Irish and 13 in the Czechs) was performed by competitive specific allele-specific PCR (KASPar). Multivariable adjusted logistic regression was used to assess the associations with CRC development. RESULTS: We found significant associations with an increased CRC risk for rs5859 (SELENOF) and rs2972994 (SELENOP) in the Irish cohort but only with rs4802034 (SELENOV) in the Czechs. Significant associations were observed for rs5859 (SELENOF), rs4659382 (SELENON), rs2972994 (SELENOP), rs34713741 (SELENOS), and the related Se metabolism gene variant rs2275129 (SEPHS1) with advanced colorectal neoplasia development. However, none of these findings retained significance after multiple testing corrections. CONCLUSIONS: Several SNPs previously associated with CRC risk were also associated with CRC or colorectal neoplasia development in either the Irish or Czech cohorts. Selenoprotein gene variation may modify CRC risk across diverse European populations, although the specific variants may differ.
650    12
$a adenom $x epidemiologie $x genetika $7 D000236
650    _2
$a studie případů a kontrol $7 D016022
650    12
$a kolorektální nádory $x epidemiologie $x genetika $7 D015179
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a prospektivní studie $7 D011446
650    _2
$a selenoprotein P $x metabolismus $7 D051149
650    _2
$a selenoproteiny $x genetika $x metabolismus $7 D051140
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ashfield, Niall $u Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland $1 https://orcid.org/0000000215365366
700    1_
$a Vodickova, Ludmila $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic $u Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic
700    1_
$a Vymetalkova, Veronika $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic $u Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic
700    1_
$a Levy, Miroslav $u Department of Surgery, First Faculty of Medicine, Charles University and Thomayer Hospital, 121 08 Prague, Czech Republic
700    1_
$a Liska, Václav $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic
700    1_
$a Bruha, Jan $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic $u Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic
700    1_
$a Bendova, Petra $u Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic
700    1_
$a O'Sullivan, Jacintha $u Trinity Translational Medicine Institute, Department of Surgery, Trinity College Dublin and St. James's Hospital, D08 NHY1 Dublin, Ireland
700    1_
$a Doherty, Glen $u Centre for Colorectal Disease, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland
700    1_
$a Sheahan, Kieran $u Centre for Colorectal Disease, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland
700    1_
$a Nolan, Blathnaid $u Centre for Colorectal Disease, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland
700    1_
$a Vodicka, Pavel $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic $u Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic
700    1_
$a Hughes, David J $u Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland $1 https://orcid.org/0000000316688770
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 14, č. 13 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35807897 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100508 $b ABA008
999    __
$a ok $b bmc $g 1854886 $s 1176679
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 13 $e 20220629 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a HRA-POS/2013/397 $p Health Research Board of Ireland
GRA    __
$a 31312020 $p International Hundred K+ Cohorts Consortium/Global Genomic Medicine Collaborative (IHCC/G2MC)
GRA    __
$a GACR 20-03997S $p Czech Science Foundation
GRA    __
$a VV 22-05942S $p Czech Science Foundation
GRA    __
$a AZV NV18-03-00199 $p Czech Health Research council of the Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace